COVID-19 Vaccinations: A Comprehensive Review of Their Safety and Efficacy in Special Populations
This review aims to evaluate the existing evidence of COVID-19 vaccinations on special populations and to provide clues to guide vaccination decision making to balance the benefits and risks of vaccinations.
Emergence of the Delta Plus variant of SARS-CoV-2 in Iran
- MedicineGene Reports
Vaccines against COVID-19 – Catching the Rays of Hope
- MedicineJournal of Pharmaceutical Research International
This review aims to elucidate the status of vaccine candidates in advanced trials along with the vaccines, which have been granted emergency approvals, and their probability of efficacy against newer variants of the virus.
SHOWING 1-2 OF 2 REFERENCES
A booster dose is immunogenic and will be needed for older adults who have completed two doses vaccination with CoronaVac: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
Importance: Whether herd immunity through mass vaccination is sufficient to curb SARS-CoV-2 transmission requires an understanding of the duration of vaccine-induced immunity, and the necessity and…
Safety and Potency of COVIran Barekat Inactivated Vaccine Candidate for SARS-CoV-2: A Preclinical Study
The results highlight the COVIran Barekat vaccine as a potential candidate to induce a strong and potent immune response which may be a promising and feasible vaccine to protect against SARS-CoV2 infection.